Skip to content
value.today
RaySearch Laboratories AB (publ) logo

RaySearch Laboratories AB (publ)

RAY-B.ST
$300 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$137 M
For year ending December-2025
Net income
$23 M
16.9% margin
Official annual report (ESEF)
Employees
—

RaySearch Laboratories AB (publ) in brief

RaySearch Laboratories AB (publ) is a listed company in the Healthcare Information Services industry, based in Sweden. Its last known market value was $300 M (January 2024); there is no current figure. In the year to December 2025 it had sales of $137 M and a net profit of $23 M, about 17 cents of profit for every dollar of sales. Its shares trade under the symbol RAY-B.ST (Stockholm).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

RaySearch Laboratories AB (publ) timeline

2 events, 1988–2017
  1. 1988
  2. 🏁
    · approximate
    Incorporated as RaySearch Laboratories AB (publ)
  3. 2017
  4. •
    Legal Entity Identifier issued
    LEI 549300TYFVYGS0JFWM28 registered.

Events of RaySearch Laboratories AB (publ) from the GLEIF LEI register. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$112 M$225 M$337 M$449 M20202021202220232024

World rank over time

▼ down 3,786 places since 2020
2020-01-01: #11981#11,98120202021-01-01: #13042#13,04220212022-01-07: #19208#19,20820222022-12-25: #17844#17,84420222023-07-30: #17263#17,26320232024-01-05: #15767#15,7672024

Rank in Sweden: #179 (Jan 2020) · #216 (Jan 2021) · #291 (Jan 2022) · #234 (Dec 2022) · #223 (Jul 2023) · #204 (Jan 2024)

Key ratios

market cap and latest results
P/E ratio
—
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
16.9%
Operating margin
21.7%
Return on equity
21.7%
Liabilities / assets
50.5%
Revenue growth
+21.3%
R&D / revenue
20.1%

Financial history

USD · fiscal years · source: official annual reports (ESEF)
RevenueNet income
Fiscal year ending Dec 2024: revenue $113M, net income $19M$113MFY24Fiscal year ending Dec 2025: revenue $137M, net income $23M$137MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$137M+21.3%$30M$23M16.9%
Dec 2024$113M—$25M$19M17.1%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$39M$3M$37M$0.68—
Dec 2024$46M$1M$45M$0.56—

Annual results

Revenue
$137 M
Operating income
$30 M
Net income
$23 M

For year ending December-2025 · source: official annual report (ESEF)

Balance sheet

Total assets
$216 M
Total liabilities
$109 M
Total equity
$107 M

As of December-2025

Mutual funds holding RaySearch Laboratories AB (publ)#

83 funds in 2 countries hold shares worth $168 M. Since their previous reports 34 added shares and 23 sold, buying $23 M net. By country: Sweden 39 ($131 M), USA 44 ($37 M).
Mutual funds holding RaySearch Laboratories AB (publ)
FundSharesValueOf the companyOf the fundChange in sharesReport
🇸🇪 Swedbank Robur Småbolagsfond SverigeSwedbank Robur Fonder AB961,850$22 M—0.80%no changeJun 30, 2026
🇸🇪 Case All Star SmåbolagCase Kapitalförvaltning AB844,154$19 M—5.7%−5.6%Jun 30, 2026
🇺🇸 Avantis International Small Cap Value ETFAmerican Century ETF Trust552,413$13 M—0.07%+16%May 31, 2026
🇸🇪 Swedbank Robur Ny TeknikSwedbank Robur Fonder AB558,183$13 M—1.1%−14%Jun 30, 2026
🇸🇪 Handelsbanken Svenska SmåbolagHandelsbanken Fonder AB475,000$11 M—0.74%+116%Jun 30, 2026
🇸🇪 Swedbank Robur ExportfondSwedbank Robur Fonder AB420,000$9 M—0.84%+45%Jun 30, 2026
🇸🇪 Humle SmåbolagsfondAtle Fund Management AB300,000$7 M—1.2%+72%Jun 30, 2026
🇸🇪 Handelsbanken Sverige Index CriteriaHandelsbanken Fonder AB273,037$6 M—0.07%+6.1%Jun 30, 2026
🇸🇪 Swedbank Robur HealthcareSwedbank Robur Fonder AB233,682$5 M—0.35%−7.6%Jun 30, 2026
🇸🇪 TIN Ny TeknikTeknik Innovation Norden Fonder AB220,000$5 M—3.5%no changeJun 30, 2026
🇸🇪 AMF Aktiefond SmåbolagAMF Fonder AB200,000$5 M—0.34%newJun 30, 2026
🇸🇪 FE Småbolag SverigeFCG Fonder AB193,527$4 M—1.3%newJun 30, 2026
🇸🇪 Lannebo Hälsa och Ny TeknikLannebo Kapitalförvaltning AB191,638$4 M—7.1%+73%Jun 30, 2026
🇸🇪 SEB Sverige IndexnäraSEB Funds AB153,942$3 M—0.05%+4.9%Jun 30, 2026
🇸🇪 Handelsbanken Norden Index CriteriaHandelsbanken Fonder AB146,072$3 M—0.09%+39%Jun 30, 2026
🇺🇸 iShares Core MSCI EAFE ETFBlackRock Fund Advisors171,044$3 M—<0.01%+1.2%Jul 31, 2026
🇺🇸 The Continental Small Company SeriesDimensional Fund Advisors LP160,951$3 M—0.04%−0.6%Jul 31, 2026
🇺🇸 International Core Equity 2 PortfolioDimensional Fund Advisors LP131,837$2 M—<0.01%no changeJul 31, 2026
🇺🇸 Avantis International Equity ETFAmerican Century ETF Trust96,704$2 M—0.01%+6.7%May 31, 2026
🇺🇸 Dimensional International Small Cap ETFDimensional Fund Advisors LP108,001$2 M—0.04%+0.7%Jul 31, 2026
🇺🇸 iShares MSCI EAFE Small-Cap ETFBlackRock Fund Advisors103,993$2 M—0.01%−9.8%Jul 31, 2026
🇸🇪 Skandia Småbolag SverigeSkandia Fonder AB82,457$2 M—0.51%newJun 30, 2026
🇸🇪 Skandia Sverige ExponeringSkandia Fonder AB79,617$2 M—0.10%no changeJun 30, 2026
🇸🇪 Aktiespararna Småbolag EdgeCicero Fonder AB75,000$2 M—2.3%no changeJun 30, 2026
🇸🇪 SEB Sverige IndexfondSEB Funds AB68,695$2 M—0.05%+14%Jun 30, 2026
🇸🇪 Storebrand Sverige PlusStorebrand Asset Management AS68,000$2 M—0.07%+11%Jun 30, 2026
🇸🇪 Lysa Sweden Equity FocusLysa Fonder AB50,003$1 M—0.69%+4.9%Jun 30, 2026
🇺🇸 Dimensional International Core Equity 2 ETFDimensional Fund Advisors LP51,691$1 M—<0.01%−6.6%Jul 31, 2026
🇸🇪 Storebrand Sverige Småbolag PlusStorebrand Asset Management AS32,500$1 M—0.21%+1.6%Jun 30, 2026
🇺🇸 William Blair International Small Cap Growth FundWilliam Blair Investment Management, LLC31,650$1 M—0.52%−2.3%Jun 30, 2026
🇸🇪 Lysa Sweden Equity BroadLysa Fonder AB26,280$1 M—0.08%+11%Jun 30, 2026
🇺🇸 State Street SPDR S&P International Small Cap ETFSSGA Funds Management, Inc.25,001$1 M—0.07%+1.0%Jun 30, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC23,387$1 M—<0.01%no changeJun 30, 2026
🇸🇪 XACT SVENSKA SMÅBOLAG (UCITS ETF)Handelsbanken Fonder AB22,260$1 M—0.26%+11%Jun 30, 2026
🇺🇸 Avantis International Small Cap Value FundAmerican Century ETF Trust20,163$0 M—0.07%−30%May 31, 2026
🇺🇸 International Vector Equity PortfolioDimensional Fund Advisors LP24,827$0 M—0.01%no changeJul 31, 2026
🇺🇸 WisdomTree International SmallCap Dividend FundWisdomTree Asset Management, Inc.20,311$0 M—0.04%+1.2%Jun 30, 2026
🇸🇪 Lannebo Teknik SmåbolagLannebo Kapitalförvaltning AB21,900$0 M—1.5%—Mar 31, 2026
🇺🇸 iShares Core MSCI Europe ETFBlackRock Fund Advisors22,966$0 M—<0.01%−2.2%Jul 31, 2026
🇺🇸 Dimensional International Core Equity Market ETFDimensional Fund Advisors LP22,496$0 M—<0.01%+7.5%Jul 31, 2026
🇺🇸 iShares International Small-Cap Equity Factor ETFBlackRock Fund Advisors21,018$0 M—0.06%−48%Jul 31, 2026
🇸🇪 Skandia BalanseradSkandia Fonder AB16,502$0 M—0.02%no changeJun 30, 2026
🇺🇸 Fidelity Total International Index FundFidelity Management & Research Company LLC17,340$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP16,035$0 M—<0.01%no changeJul 31, 2026
🇺🇸 International Sustainability Core 1 PortfolioDimensional Fund Advisors LP14,641$0 M—<0.01%no changeJul 31, 2026
🇸🇪 Aktiespararna AktivCicero Fonder AB11,146$0 M—1.7%−14%Jun 30, 2026
🇸🇪 Skandia Världen SverigeSkandia Fonder AB11,096$0 M—0.03%no changeJun 30, 2026
🇺🇸 WisdomTree Dynamic International Equity FundWisdomTree Asset Management, Inc.10,785$0 M—0.02%+58%Jun 30, 2026
🇸🇪 Handelsbanken Global Småbolag Index CriteriaHandelsbanken Fonder AB10,678$0 M—0%+67%Jun 30, 2026
🇸🇪 PLUS Småbolag Sverige IndexISEC Services AB10,579$0 M—0.20%−0.7%Jun 30, 2026
🇸🇪 PLUS Allabolag Sverige IndexISEC Services AB10,328$0 M—0.05%+1.0%Jun 30, 2026
🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP10,869$0 M—<0.01%no changeJul 31, 2026
🇸🇪 Lannebo Marknad Sverige BredLannebo Kapitalförvaltning AB8,900$0 M—0.04%−29%Jun 30, 2026
🇸🇪 Nordnet Småbolag Sverige IndexNordnet Fonder AB8,558$0 M—0.39%−13%Jun 30, 2026
🇺🇸 WisdomTree Dynamic International SmallCap Equity FundWisdomTree Asset Management, Inc.8,457$0 M—0.05%−5.6%Jun 30, 2026
🇺🇸 State Street SPDR Portfolio MSCI Global Stock Market ETFSSGA Funds Management, Inc.8,368$0 M—0.01%+266%Jun 30, 2026
🇺🇸 State Street Global All Cap Equity ex-U.S. Index PortfolioSSGA Funds Management, Inc.8,022$0 M—<0.01%no changeJun 30, 2026
🇸🇪 Cicero SverigeCicero Fonder AB8,068$0 M—0.84%no changeJun 30, 2026
🇺🇸 Brighthouse/Dimensional International Small Company PortfolioBrighthouse Investment Advisers, LLC7,299$0 M—0.04%no changeJun 30, 2026
🇺🇸 Fidelity SAI International Small Cap Index FundFidelity Management & Research Company LLC8,133$0 M—0.01%−5.5%Jul 31, 2026
🇺🇸 Dimensional International Sustainability Core 1 ETFDimensional Fund Advisors LP8,007$0 M—0.01%+11%Jul 31, 2026
🇺🇸 International Small Cap Growth PortfolioDimensional Fund Advisors LP7,143$0 M—0.04%no changeJul 31, 2026
🇺🇸 WisdomTree Europe SmallCap Dividend FundWisdomTree Asset Management, Inc.5,529$0 M—0.08%no changeJun 30, 2026
🇺🇸 International Social Core Equity PortfolioDimensional Fund Advisors LP6,360$0 M—<0.01%no changeJul 31, 2026
🇸🇪 Kvartil Nordiska Småbolag+ FaktorQuartile Fonder AB4,872$0 M—0.34%+137%Jun 30, 2026
🇺🇸 Avantis International Small Cap Equity ETFAmerican Century ETF Trust4,329$0 M—0.03%+18%May 31, 2026
🇺🇸 Dimensional VA International Small PortfolioDimensional Fund Advisors LP5,421$0 M—0.02%no changeJul 31, 2026
🇸🇪 Småbolag Sverige ExponeringSkandia Fonder AB4,120$0 M—0.24%+14%Jun 30, 2026
🇺🇸 WisdomTree International Equity FundWisdomTree Asset Management, Inc.3,577$0 M—0.01%−1.6%Jun 30, 2026
🇺🇸 Avantis International Equity FundAmerican Century ETF Trust3,339$0 M—<0.01%+32%May 31, 2026
🇺🇸 Avantis Responsible International Equity ETFAmerican Century ETF Trust2,885$0 M—0.01%+0.9%May 31, 2026
🇺🇸 iShares MSCI Europe Small-Cap ETFBlackRock Fund Advisors3,216$0 M—0.03%−3.8%Jul 31, 2026
🇺🇸 International Small Company TrustJohn Hancock Variable Trust Advisers LLC2,452$0 M—0.05%no changeJun 30, 2026
🇺🇸 LVIP Dimensional International Core Equity FundLincoln Financial Investments Corporation2,208$0 M—<0.01%no changeJun 30, 2026
🇸🇪 Avanza SwedenAvanza Fonder AB1,841$0 M—0.08%—Jun 30, 2026
🇺🇸 iShares MSCI World Small-Cap ETFBlackRock Fund Advisors1,742$0 M—<0.01%−24%May 31, 2026
🇸🇪 Skandia FörsiktigSkandia Fonder AB1,573$0 M—0.01%no changeJun 30, 2026
🇺🇸 Parametric International Equity FundEaton Vance Management1,617$0 M—0.01%newJul 31, 2026
🇺🇸 AZL DFA International Core Equity FundAllianz Investment Management LLC1,213$0 M—<0.01%no changeJun 30, 2026
🇸🇪 Skandia Mix 60 ExponeringSkandia Fonder AB1,140$0 M—0.01%no changeJun 30, 2026
🇸🇪 Skandia Mix 100 ExponeringSkandia Fonder AB1,082$0 M—0.01%no changeJun 30, 2026
🇺🇸 State Street SPDR Portfolio Europe ETFSSGA Funds Management, Inc.1,063$0 M—<0.01%−2.2%Jun 30, 2026
🇺🇸 Dimensional International Vector Equity ETFDimensional Fund Advisors LP839$0 M—<0.01%no changeJul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 83 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

RaySearch Laboratories AB (publ) scorecard#

Passes 5 of the 5 checks that could be worked out. Fiscal year 2025.

  • Valuationnot known
    • –P/E below its peers' medianNo market cap.
    • –Price to book below its peers' medianNo market cap.
    • –Price to sales below its peers' medianNo market cap.
    • –Free cash flow yield above 5%No market cap.
    • –Earnings yield above the 10-year Treasury yieldNo market cap.
    • –The price assumes slower growth than the last three years'No market cap.
  • Growth2 of 2
    • ✓Revenue grew in the newest year21.3%Revenue up 21.3% in fiscal 2025.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • ✓Earnings per share grew in the newest year0.68 vs 0.56Diluted EPS 0.68 in fiscal 2025 against 0.56 the year before (report's currency).
    • –Net income higher than five years earlierNet income of five years earlier is not on file.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability3 of 3
    • ✓Profitable in the newest year$23 MNet income $23 M in fiscal 2025.
    • –Profitable in each of the last five yearsFive years of net income are not on file.
    • ✓Operating margin above its peers' median21.7%21.7% against Healthcare Information Services's median of -7.1% (29 companies).
    • ✓Return on equity above 15%24.9%24.9% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial healthnot known
    • –Short-term assets cover short-term liabilitiesCurrent assets and liabilities are not on file.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • –Cash from operations positive in each of the last three yearsThree years of operating cash flow are not on file.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returnsnot known
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • –Share count up no more than 2% in a yearShare counts of two years are not on file.
    • –Dividends and buybacks above 3% of the market valueNo market cap.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (esef), the medians of Healthcare Information Services, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from RaySearch Laboratories AB (publ)'s statements, beside the median of Healthcare Information Services.

RaySearch Laboratories AB (publ): main financial ratios in 2025
Ratio2025Median of peers
Operating margin21.7%-7.1%
Net margin16.9%-6.8%
Return on equity24.9%-0.8%
Revenue growth21.3%8.7%
Free cash flow margin26.7%14.1%

6of 6on the Piotroski tests of financial strength

RaySearch Laboratories AB (publ): financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in SEK millions; per-share figures in SEK; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

RaySearch Laboratories AB (publ): statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020
Income statement
Revenue1,3441,1921,022844642652
Cost of revenue102100107955043
Gross profit1,2421,093916749591608
Research and development270269238239233185
Selling and marketing————300291
General and administrative288250195172122106
Operating income29226111543−53−3.5
Interest and finance income7.1114.91.10.72.7
Interest expense and finance costs129.09.7116.05.7
Income before tax28826311032−59−6.5
Income tax6059298.6−112.6
Net income including minority interests2282048224−47−9.1
Earnings per share, basic6.655.942.380.69-138.00-26.00
Earnings per share, diluted6.655.942.380.69——
Balance sheet
Cash and cash equivalents407463344160103169
Receivables240255240250171157
Inventory22119.314309.1
Current assets971985802628516577
Property, plant and equipment637090109——
Right-of-use (leased) assets38445750154054093
Other intangible assets5.67.00.10.3——
Non-current assets1,0211,1061,1501,2481,223708
Total assets1,9922,0911,9531,8761,7391,285
Accounts payable————4920
Current liabilities570704675637490428
Lease liabilities (non-current)317395432474——
Non-current liabilities437511542582600163
Total liabilities1,0071,2151,2171,2191,090591
Retained earnings982857722640638685
Shareholders' equity985877735657649694
Total equity985877735657649694
Total liabilities and equity1,9922,0911,9531,8761,7391,285
Cash-flow statement
Depreciation and amortization————0.10.1
Cash from operating activities387485456321238332
Capital expenditure−28−13−24−13−52−30
Intangible assets bought0−7.0——−203−196
Cash from investing activities−228−218−209−201−238−226
Debt repaid————−500
Dividends paid−103−69————
Cash from financing activities−180−160−56−72−72−44
Exchange-rate effect on cash−3511−6.8115.5−7.0
ReportESEFESEFESEFESEFESEFESEF

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: ESEF annual reports (filings.xbrl.org) · as of Dec 31, 2025. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

How RaySearch Laboratories AB (publ) compares in Healthcare Information Services

  • Revenue$137 M · higher than 30% of 70
  • Net margin16.9% · higher than 88% of 68
  • Revenue growth21.3% · higher than 89% of 38

Peer comparison · Healthcare Information Services

CompanyMarket capP/ENet marginRev. growth
RaySearch Laboratories AB (publ)🇸🇪$300 M—16.9%+21.3%
Veeva Systems Inc.🇺🇸$50.2 B49.5×29.4%+16.3%
Pro Medicus Limited🇦🇺$14.4 B81.3×——
10x Genomics, Inc.🇺🇸$9.4 B—-10.8%+5.3%
HealthEquity, Inc.🇺🇸$8.3 B35.3×17.4%+9.5%
M3, Inc.🇯🇵$7.1 B21.5×14.0%—
Doximity, Inc.🇺🇸$5.5 B39.5×21.1%+13.1%
Privia Health Group, Inc.🇺🇸$2.8 B80.9×1.4%+22.3%
Winning Health Technology Group Co., Ltd.🇨🇳$2.3 B41.3×13.8%—

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Profile updated:
Nov 15, 2026

Figures from Official annual report (ESEF), value.today research, GLEIF register.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at RaySearch Laboratories AB (publ)? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show RaySearch Laboratories AB (publ)'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about RaySearch Laboratories AB (publ)? Suggest a correction